RiboX Therapeutics
Entry
2021
Hold
5yr
Status
Active
Who owns RiboX Therapeutics?
RiboX Therapeutics is currently owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), since 2021.
Hand-verified · updated 2026-07-03
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
US
Germany
Switzerland
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track RiboX Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy RiboX Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on RiboX Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue